1. Home
  2. ALAR vs ZNTL Comparison

ALAR vs ZNTL Comparison

Compare ALAR & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALAR
  • ZNTL
  • Stock Information
  • Founded
  • ALAR 2013
  • ZNTL 2014
  • Country
  • ALAR Israel
  • ZNTL United States
  • Employees
  • ALAR N/A
  • ZNTL N/A
  • Industry
  • ALAR Computer Software: Prepackaged Software
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALAR Technology
  • ZNTL Health Care
  • Exchange
  • ALAR Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • ALAR 200.6M
  • ZNTL 300.4M
  • IPO Year
  • ALAR 2018
  • ZNTL 2020
  • Fundamental
  • Price
  • ALAR $26.95
  • ZNTL $3.70
  • Analyst Decision
  • ALAR Buy
  • ZNTL Buy
  • Analyst Count
  • ALAR 2
  • ZNTL 7
  • Target Price
  • ALAR $32.50
  • ZNTL $13.14
  • AVG Volume (30 Days)
  • ALAR 745.1K
  • ZNTL 1.6M
  • Earning Date
  • ALAR 08-22-2024
  • ZNTL 08-07-2024
  • Dividend Yield
  • ALAR N/A
  • ZNTL N/A
  • EPS Growth
  • ALAR N/A
  • ZNTL N/A
  • EPS
  • ALAR N/A
  • ZNTL N/A
  • Revenue
  • ALAR $29,218,000.00
  • ZNTL $40,560,000.00
  • Revenue This Year
  • ALAR $41.21
  • ZNTL N/A
  • Revenue Next Year
  • ALAR $25.00
  • ZNTL N/A
  • P/E Ratio
  • ALAR N/A
  • ZNTL N/A
  • Revenue Growth
  • ALAR 43.58
  • ZNTL N/A
  • 52 Week Low
  • ALAR $2.07
  • ZNTL $3.27
  • 52 Week High
  • ALAR $46.69
  • ZNTL $29.03
  • Technical
  • Relative Strength Index (RSI)
  • ALAR 38.60
  • ZNTL 30.12
  • Support Level
  • ALAR $26.62
  • ZNTL $3.83
  • Resistance Level
  • ALAR $46.00
  • ZNTL $4.79
  • Average True Range (ATR)
  • ALAR 3.89
  • ZNTL 0.44
  • MACD
  • ALAR -1.68
  • ZNTL 0.26
  • Stochastic Oscillator
  • ALAR 1.64
  • ZNTL 28.29

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: